抗癌药物拉莫司汀[14C]-VNP40101M在大鼠、狗、猴和人肝微粒体的体外分析和质量平衡

A-E. F. Nassar, J. Du, M. Belcourt, X. Lin, I. King
{"title":"抗癌药物拉莫司汀[14C]-VNP40101M在大鼠、狗、猴和人肝微粒体的体外分析和质量平衡","authors":"A-E. F. Nassar, J. Du, M. Belcourt, X. Lin, I. King","doi":"10.2174/1874073101004010001","DOIUrl":null,"url":null,"abstract":"Laromustine (VNP40101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine) is a novel sulfonylhydrazine alkylating agent. For the first time In vitro profiling and mass balance of ( 14 C)-VNP40101M in rat, dog, monkey and human liver microsomes was investigated. Also, the role of human cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) enzymes in the conversion of ( 14 C)-VNP40101M by NADPH-fortified human liver microsomes was determined. In this study, ( 14 C)-VNP40101M was converted to five radioactive components (C-1, C-2, C-3, C-4 and C-7) after 60 min of incubation with dog, monkey and human liver microsomes. With the exception of C-3, the same components were detected with rat liver microsomes. In the presence of NADPH, after 60 min of incuba- tion, the loss of substrate for rat, dog, monkey and human was 63, 82, 76 and 64%, respectively and mass balance ranged from 91.0 - 99.3%. In the absence of NADPH, after 60 min of incubation with ( 14 C)-VNP40101M (100 �M), the loss of substrate for rat, dog, monkey and human liver microsomes was 59, 53, 61 and 59%, respectively and mass balance ranged from 100.6 - 116.4%. The profiles of metabolites were similar. The relative abundance of individual metabolites was not species dependent. The formation of C-7 was not observed in zero-cofactor (no NADPH) or zero-protein samples, suggesting that its formation was enzymatic. The formation of C-1, C-2, C-3, and C-4 increased with respect to incubation time. Using a panel of CYP enzymes including rCYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4, it was shown that C- 7 formation was catalyzed by CYP2B6 and CYP3A4/5. The results of this study suggest that (1) P450 plays a role in C-7 formation but plays little or no role in the conversion of ( 14 C)-VNP40101M to C-1 through C-4, and (2) the relative abun- dance of individual degradation/metabolite products were not species dependent. These findings provide a comprehensive understanding of the metabolism of this new agent.","PeriodicalId":89636,"journal":{"name":"The open drug metabolism journal","volume":"4 1","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"In Vitro Profiling and Mass Balance of the Anti-Cancer Agent Laromustine [14C]-VNP40101M by Rat, Dog, Monkey and Human Liver Microsomes\",\"authors\":\"A-E. F. Nassar, J. Du, M. Belcourt, X. Lin, I. King\",\"doi\":\"10.2174/1874073101004010001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Laromustine (VNP40101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine) is a novel sulfonylhydrazine alkylating agent. For the first time In vitro profiling and mass balance of ( 14 C)-VNP40101M in rat, dog, monkey and human liver microsomes was investigated. Also, the role of human cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) enzymes in the conversion of ( 14 C)-VNP40101M by NADPH-fortified human liver microsomes was determined. In this study, ( 14 C)-VNP40101M was converted to five radioactive components (C-1, C-2, C-3, C-4 and C-7) after 60 min of incubation with dog, monkey and human liver microsomes. With the exception of C-3, the same components were detected with rat liver microsomes. In the presence of NADPH, after 60 min of incuba- tion, the loss of substrate for rat, dog, monkey and human was 63, 82, 76 and 64%, respectively and mass balance ranged from 91.0 - 99.3%. In the absence of NADPH, after 60 min of incubation with ( 14 C)-VNP40101M (100 �M), the loss of substrate for rat, dog, monkey and human liver microsomes was 59, 53, 61 and 59%, respectively and mass balance ranged from 100.6 - 116.4%. The profiles of metabolites were similar. The relative abundance of individual metabolites was not species dependent. The formation of C-7 was not observed in zero-cofactor (no NADPH) or zero-protein samples, suggesting that its formation was enzymatic. The formation of C-1, C-2, C-3, and C-4 increased with respect to incubation time. Using a panel of CYP enzymes including rCYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4, it was shown that C- 7 formation was catalyzed by CYP2B6 and CYP3A4/5. The results of this study suggest that (1) P450 plays a role in C-7 formation but plays little or no role in the conversion of ( 14 C)-VNP40101M to C-1 through C-4, and (2) the relative abun- dance of individual degradation/metabolite products were not species dependent. These findings provide a comprehensive understanding of the metabolism of this new agent.\",\"PeriodicalId\":89636,\"journal\":{\"name\":\"The open drug metabolism journal\",\"volume\":\"4 1\",\"pages\":\"1-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The open drug metabolism journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874073101004010001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open drug metabolism journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874073101004010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

摘要

Laromustine (VNP40101M;1,2-二(甲基磺酰基)-1-(2-氯乙基)-2-(甲氨基)羰基肼)是一种新型磺酰肼烷基化剂。首次研究了(14c)-VNP40101M在大鼠、狗、猴和人肝微粒体中的体外分析和质量平衡。同时,测定了人细胞色素P450 (CYP)和含黄素单加氧酶(FMO)酶在nadph强化人肝微粒体转化(14c)-VNP40101M中的作用。在本研究中,(14c)-VNP40101M与狗、猴和人肝微粒体孵育60 min后,转化为5种放射性成分(C-1、C-2、C-3、C-4和C-7)。除C-3外,在大鼠肝微粒体中检测到相同的成分。在NADPH存在的情况下,接种60 min后,大鼠、狗、猴和人的底物损失率分别为63%、82%、76%和64%,质量平衡范围为91.0 ~ 99.3%。在没有NADPH的情况下,用(14 C)- vnp40101m (100 μ M)孵育60 min后,大鼠、狗、猴和人肝微粒体的底物损失分别为59%、53%、61%和59%,质量平衡范围为100.6 - 116.4%。代谢物谱相似。个体代谢物的相对丰度不依赖于物种。在无辅酶因子(无NADPH)或无蛋白的样品中未观察到C-7的形成,表明其形成是酶促的。C-1、C-2、C-3和C-4的形成随孵育时间的延长而增加。利用一组cyp1a2、2A6、2B6、2C8、2C9、2C19、2D6和3A4等CYP酶,发现CYP2B6和CYP3A4/5催化了C- 7的形成。本研究结果表明(1)P450在C-7的形成中起作用,但在(14c)- vnp40101m通过C-4转化为C-1的过程中作用很小或没有作用;(2)个体降解/代谢产物的相对丰度不依赖于物种。这些发现提供了对这种新药物代谢的全面了解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
In Vitro Profiling and Mass Balance of the Anti-Cancer Agent Laromustine [14C]-VNP40101M by Rat, Dog, Monkey and Human Liver Microsomes
Laromustine (VNP40101M; 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino) carbonylhydrazine) is a novel sulfonylhydrazine alkylating agent. For the first time In vitro profiling and mass balance of ( 14 C)-VNP40101M in rat, dog, monkey and human liver microsomes was investigated. Also, the role of human cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO) enzymes in the conversion of ( 14 C)-VNP40101M by NADPH-fortified human liver microsomes was determined. In this study, ( 14 C)-VNP40101M was converted to five radioactive components (C-1, C-2, C-3, C-4 and C-7) after 60 min of incubation with dog, monkey and human liver microsomes. With the exception of C-3, the same components were detected with rat liver microsomes. In the presence of NADPH, after 60 min of incuba- tion, the loss of substrate for rat, dog, monkey and human was 63, 82, 76 and 64%, respectively and mass balance ranged from 91.0 - 99.3%. In the absence of NADPH, after 60 min of incubation with ( 14 C)-VNP40101M (100 �M), the loss of substrate for rat, dog, monkey and human liver microsomes was 59, 53, 61 and 59%, respectively and mass balance ranged from 100.6 - 116.4%. The profiles of metabolites were similar. The relative abundance of individual metabolites was not species dependent. The formation of C-7 was not observed in zero-cofactor (no NADPH) or zero-protein samples, suggesting that its formation was enzymatic. The formation of C-1, C-2, C-3, and C-4 increased with respect to incubation time. Using a panel of CYP enzymes including rCYP1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4, it was shown that C- 7 formation was catalyzed by CYP2B6 and CYP3A4/5. The results of this study suggest that (1) P450 plays a role in C-7 formation but plays little or no role in the conversion of ( 14 C)-VNP40101M to C-1 through C-4, and (2) the relative abun- dance of individual degradation/metabolite products were not species dependent. These findings provide a comprehensive understanding of the metabolism of this new agent.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信